Optimising The Management Of Comorbidities In Dementia: Reducing Disparaties And Improving Clinical Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$603,894.00
Summary
Many individuals with dementia also have other chronic medical conditions. This research will help us better understand the comorbidities experienced by people with dementia and the impact these have on clinical outcomes This can lead to the development of consumer-centred management strategies. By ensuring the appropriate, equitable and timely treatment of comorbidities in people with dementia, there is potential to optimise the quality of life and health of people with dementia.
Optimising Medicine Regimens For People With Dementia: Maintaining Function, Maximising Quality Of Life And Preventing Adverse Events
Funder
National Health and Medical Research Council
Funding Amount
$715,017.00
Summary
I am a pharmacist based at Monash University. My expanding research team generates and applies evidence to optimise medicine regimens for people with dementia. My research assesses the risks and benefits of medicines for dementia and other health conditions. I will also focus on research training and capacity building. My research ensures people with dementia and their clinicians are equipped with the best evidence to inform medicines management decisions to optimise health outcomes.
Optimising Pharmaceutical Care For People With Dementia In Acute Care Settings
Funder
National Health and Medical Research Council
Funding Amount
$719,637.00
Summary
Delivering appropriate acute care services for people with dementia is a major healthcare challenge in Australia. People with dementia do not receive appropriate care in hospitals and are more likely to experience worse clinical outcomes compared to people without dementia. This proposal will establish the first large-scale multi-centre cohort of inpatients with dementia, to systematically investigate the impact of hospitalisation on prescribing, clinical and patient-centred outcomes.
Medicine-associated Dementia And Cognitive Impairment: Identifying The Problem, Reducing The Harm
Funder
National Health and Medical Research Council
Funding Amount
$513,116.00
Summary
Several studies have shown an association between use of anticholinergic or sedative medicines and increased risk of dementia. Questions remain about whether these medicines cause dementia (or are just used by people already at risk), whether or not cognitive function improves if the medicines are stopped or if the dose is reduced, and the characteristics of patients most likely to use these medicines. This program of research aims to answer these questions.
Development Of A Unified List Of Drugs Associated With Drug-induced Cognitive Impairment
Funder
National Health and Medical Research Council
Funding Amount
$443,573.00
Summary
This research will develop a comprehensive list of drugs probably impairing cognition. These drugs will be identified from a large spontaneous reporting system in combination with those from published literature. The association of identified drugs and cognitive impairment will be tested using prescription sequence symmetry analyses in Pharmaceutical Benefits Scheme claims database and validated through formal epidemiological studies in Australian ongoing longitudinal population-based cohorts.